GTPBP3 (Q969Y2), human: research report
Claude Code
claude-haiku-5-5, claude-sonnet-5-5
6 citations
2026-10-14T23:18:04.364566
GTPBP3 (Q969Y2), human: research report
Identity check
The symbol, organism and protein description all match. UniProt Q969Y2 is human GTPBP3, the "5-taurinomethyluridine-[tRNA] synthase subunit GTPB3, mitochondrial" (also called tRNA modification GTPase GTPBP3 or MTGP1). It belongs to the TrmE-Era-EngA-EngB-Septin-like TRAFAC GTPase class. Its domains are G_TrmE, GTPase_MnmE and the MnmE N-terminal and domain-2 regions. The literature below concerns this same protein, so there is no ambiguity.
Some details come only from search-result summaries, not from full-text reading of every paper. I flag these below. Quoted passages should be checked against the cached publications/PMID_*.md files before they are used as supporting_text.
Primary function
GTPBP3 is the human ortholog of bacterial MnmE (also called TrmE). It works with MTO1, the ortholog of MnmG/GidA, to modify the wobble uridine (U34) of mitochondrial tRNAs. In human mitochondria the product is 5-taurinomethyluridine (τm5U), made by attaching a methylene-taurine group to C5 of the uracil. Yeast and E. coli make the glycine-containing analog (cmnm5U) instead.
- Reaction. GTPBP3 and MTO1 transform U34 into τm5U34 in tRNA. Reactome annotates this as a single event, R-HSA-6787403. The bacterial paradigm is that the MnmE/MnmG complex uses GTP hydrolysis, a one-carbon donor (methylene-tetrahydrofolate) and the amino-acid substrate, here taurine. The mechanism is still not fully understood.
- Substrates. The five human mitochondrial tRNAs carrying τm5U34 are tRNALys, tRNAGlu, tRNAGln, tRNALeu(UUR) and tRNATrp. This follows from the Kopajtich et al. description summarized below and is consistent with the literature. Check the exact list against the cached paper.
- Enzyme activity. The UniProt entry annotates EC 3.6.1.- (GTPase activity), citing PMID:29390138(https://pmc.ncbi.nlm.nih.gov/articles/PMC5829720) and PMID:33619562(https://pmc.ncbi.nlm.nih.gov/articles/PMC7969015).
- Earlier work found that two abundant GTPBP3 isoforms bind guanine nucleotides with moderate affinity but hydrolyze GTP about 100 times more slowly than MnmE. The N-terminal domain mediates potassium-independent dimerization.
- Peng and colleagues (Nucleic Acids Research, 2021, PMID:33619562) identified the mature form of the protein. They showed it is an active GTPase in vitro and is needed for tRNA modification in vivo. The isolated G domain and an N-terminal-truncated mutant hydrolyzed GTP poorly, with high Km values.
- Cooperation with MTO1. The two proteins act together in the same pathway, and GTPBP3 is not a stand-alone methyltransferase. The mechanistic details in this section come mainly from MnmE/MnmG homology and the summaries of the 2021 paper.
Evidence from patients and cells
- Kopajtich et al., AJHG 2015. Eleven individuals from nine families carried GTPBP3 mutations. All had lactic acidosis, and nine developed hypertrophic cardiomyopathy. Most also had neurological symptoms, with MRI involvement of the thalamus, putamen and brainstem resembling Leigh syndrome. This differs from MTO1 mutation carriers. Cells showed a severe mitochondrial translation defect, consistent with loss of τm5U in the five tRNAs. I did not retrieve the PMID, so look it up before citing.
- PMID:29390138 (2018). Patient cells with GTPBP3 mutations had very little τm5U34. Taurine starvation lowered τm5U levels in cultured cells and animal tissues, which supports taurine as the physiological substrate. This is the source of UniProt's catalytic annotation. Zebrafish gtpbp3 knockout models were also used in this work.
- Interpretation. The cardiomyopathy and lactic acidosis phenotype matches that of MTO1 deficiency, which is also linked to hypertrophic cardiomyopathy. The more neurological, Leigh-like presentation in GTPBP3 patients suggests GTPBP3 has some non-redundant role. This is an inference from the clinical comparison and has not been tested directly.
Localization and pathway
- Where it acts. GTPBP3 is a mitochondrial matrix protein, as the UniProt name "mitochondrial" and the precursor flag indicate. The mature form lacks the N-terminal presequence (PMID:33619562). It modifies tRNAs there, so the modification step is part of mitochondrial tRNA processing and wobble-uridine modification.
- Pathway. Its pathway is mitochondrial tRNA wobble modification: tRNA thio-modification and the U34 → τm5U34 step, followed in some tRNAs by 2-thiolation through the separate MTU1/TRMU enzyme. The τm5U modification supports accurate decoding of NNA/NNG codons in mitochondrial translation. Loss of it reduces translation of the mtDNA-encoded OXPHOS subunits and impairs oxidative phosphorylation.
Suggested GO-level summary
- Molecular function: tRNA wobble uridine modification enzyme activity, forming τm5U34. For the GTP-hydrolysing part, annotate GTPase activity and GTP binding. Avoid a generic "protein binding" term.
- Biological process: mitochondrial tRNA modification and wobble uridine modification, with mitochondrial translation as a downstream context. The MTO1 partnership could be captured as a complex annotation.
- Cellular component: mitochondrion (matrix).
Caveats and open questions
- This report rests on two web searches and the summaries they returned, not on full-text review of the primary papers. The 2015 AJHG details, the exact tRNA list, and any quantitative kinetics need checking against the primary papers.
- The bacterial MnmE/MnmG mechanism is the model for the reaction scheme. It was not demonstrated for the human enzymes in the sources I retrieved.
- The contribution of GTP hydrolysis cycling to catalysis is still unresolved.
- Whether GTPBP3 has substrate-recognition roles distinct from MTO1 could be tested experimentally.
Sources
Citations
- https://reactome.org/content/detail/R-HSA-6787403
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5829720
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7969015
- https://orca.cardiff.ac.uk/id/eprint/118889/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2593442
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10415153